-
Something wrong with this record ?
Metabolism of primary high-grade serous ovarian carcinoma (HGSOC) cells under limited glutamine or glucose availability
D. Šimčíková, D. Gardáš, T. Pelikán, L. Moráň, M. Hruda, K. Hložková, T. Pivetta, M. Hendrych, J. Starková, L. Rob, P. Vaňhara, P. Heneberg
Status not-indexed Language English Country England, Great Britain
Document type Journal Article
Grant support
324421
Univerzita Karlova v Praze
324421
Univerzita Karlova v Praze
324421
Univerzita Karlova v Praze
NU21-03-00539
Agentura Pro Zdravotnický Výzkum České Republiky
NLK
BioMedCentral
from 2013-12-01
BioMedCentral Open Access
from 2013
Directory of Open Access Journals
from 2013
Free Medical Journals
from 2013
PubMed Central
from 2013
Europe PubMed Central
from 2013
ProQuest Central
from 2015-01-01
Open Access Digital Library
from 2013-01-01
Open Access Digital Library
from 2013-01-01
Health & Medicine (ProQuest)
from 2015-01-01
Health Management Database (ProQuest)
from 2015-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2013
Springer Nature OA/Free Journals
from 2013-12-01
- Publication type
- Journal Article MeSH
BACKGROUND: High-grade serous ovarian carcinoma (HGSOC) is the most common and aggressive subtype of epithelial ovarian carcinoma. It is primarily diagnosed at stage III or IV when the 5-year survival rate ranges between 20% and 40%. Here, we aimed to validate the hypothesis, based on HGSOC cell lines, that proposed the existence of two distinct groups of HGSOC cells with high and low oxidative phosphorylation (OXPHOS) metabolism, respectively, which are associated with their responses to glucose and glutamine withdrawal. METHODS: We isolated and cultivated primary cancer cell cultures from HGSOC and nontransformed ovarian fibroblasts from the surrounding ovarium of 45 HGSOC patients. We tested the metabolic flexibility of the primary cells, particularly in response to glucose and glutamine depletion, analyzed and modulated endoplasmic reticulum stress, and searched for indices of the existence of previously reported groups of HGSOC cells with high and low OXPHOS metabolism. RESULTS: The primary HGSOC cells did not form two groups with high and low OXPHOS that responded differently to glucose and glutamine availabilities in the cell culture medium. Instead, they exhibited a continuum of OXPHOS phenotypes. In most tumor cell isolates, the responses to glucose or glutamine withdrawal were mild and surprisingly correlated with those of nontransformed ovarian fibroblasts from the same patients. The growth of tumor-derived cells in the absence of glucose was positively correlated with the lipid trafficking regulator FABP4 and was negatively correlated with the expression levels of HK2 and HK1. The correlations between the expression of electron transport chain (ETC) proteins and the oxygen consumption rates or extracellular acidification rates were weak. ER stress markers were strongly expressed in all the analyzed tumors. ER stress was further potentiated by tunicamycin but not by the recently proposed ER stress inducers based on copper(II)-phenanthroline complexes. ER stress modulation increased autophagy in tumor cell isolates but not in nontransformed ovarian fibroblasts. CONCLUSIONS: Analysis of the metabolism of primary HGSOC cells rejects the previously proposed hypothesis that there are distinct groups of HGSOC cells with high and low OXPHOS metabolism that respond differently to glutamine or glucose withdrawal and are characterized by ETC protein levels.
1st Department of Pathology Faculty of Medicine Masaryk University Brno Czech Republic
1st Department of Pathology St Anne's University Hospital Brno Czech Republic
3rd Faculty of Medicine Charles University Ruská 87 Prague CZ 100 00 Czech Republic
Department of Chemical and Geological Sciences University of Cagliari Monserrato CA Italy
Department of Histology and Embryology Faculty of Medicine Masaryk University Brno Czech Republic
International Clinical Research Center St Anne's University Hospital Brno Czech Republic
Motol University Hospital Prague Czech Republic
Research Centre for Applied Molecular Oncology Masaryk Memorial Cancer Institute Brno Czech Republic
University Hospital Kralovské Vinohrady Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24017809
- 003
- CZ-PrNML
- 005
- 20241016081829.0
- 007
- ta
- 008
- 241008s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s40170-024-00355-1 $2 doi
- 035 __
- $a (PubMed)39285269
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Šimčíková, Daniela $u Third Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic
- 245 10
- $a Metabolism of primary high-grade serous ovarian carcinoma (HGSOC) cells under limited glutamine or glucose availability / $c D. Šimčíková, D. Gardáš, T. Pelikán, L. Moráň, M. Hruda, K. Hložková, T. Pivetta, M. Hendrych, J. Starková, L. Rob, P. Vaňhara, P. Heneberg
- 520 9_
- $a BACKGROUND: High-grade serous ovarian carcinoma (HGSOC) is the most common and aggressive subtype of epithelial ovarian carcinoma. It is primarily diagnosed at stage III or IV when the 5-year survival rate ranges between 20% and 40%. Here, we aimed to validate the hypothesis, based on HGSOC cell lines, that proposed the existence of two distinct groups of HGSOC cells with high and low oxidative phosphorylation (OXPHOS) metabolism, respectively, which are associated with their responses to glucose and glutamine withdrawal. METHODS: We isolated and cultivated primary cancer cell cultures from HGSOC and nontransformed ovarian fibroblasts from the surrounding ovarium of 45 HGSOC patients. We tested the metabolic flexibility of the primary cells, particularly in response to glucose and glutamine depletion, analyzed and modulated endoplasmic reticulum stress, and searched for indices of the existence of previously reported groups of HGSOC cells with high and low OXPHOS metabolism. RESULTS: The primary HGSOC cells did not form two groups with high and low OXPHOS that responded differently to glucose and glutamine availabilities in the cell culture medium. Instead, they exhibited a continuum of OXPHOS phenotypes. In most tumor cell isolates, the responses to glucose or glutamine withdrawal were mild and surprisingly correlated with those of nontransformed ovarian fibroblasts from the same patients. The growth of tumor-derived cells in the absence of glucose was positively correlated with the lipid trafficking regulator FABP4 and was negatively correlated with the expression levels of HK2 and HK1. The correlations between the expression of electron transport chain (ETC) proteins and the oxygen consumption rates or extracellular acidification rates were weak. ER stress markers were strongly expressed in all the analyzed tumors. ER stress was further potentiated by tunicamycin but not by the recently proposed ER stress inducers based on copper(II)-phenanthroline complexes. ER stress modulation increased autophagy in tumor cell isolates but not in nontransformed ovarian fibroblasts. CONCLUSIONS: Analysis of the metabolism of primary HGSOC cells rejects the previously proposed hypothesis that there are distinct groups of HGSOC cells with high and low OXPHOS metabolism that respond differently to glutamine or glucose withdrawal and are characterized by ETC protein levels.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gardáš, Dominik $u Third Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic
- 700 1_
- $a Pelikán, Tomáš $u Third Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic
- 700 1_
- $a Moráň, Lukáš $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Brno, Czech Republic
- 700 1_
- $a Hruda, Martin $u Third Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic $u University Hospital Kralovské Vinohrady, Prague, Czech Republic
- 700 1_
- $a Hložková, Kateřina $u Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, CLIP - Childhood Leukaemia Investigation Prague, Charles University, Prague, Czech Republic
- 700 1_
- $a Pivetta, Tiziana $u Department of Chemical and Geological Sciences, University of Cagliari, Monserrato, CA, Italy
- 700 1_
- $a Hendrych, Michal $u First Department of Pathology, St. Anne's University Hospital, Brno, Czech Republic $u First Department of Pathology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Starková, Júlia $u Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, CLIP - Childhood Leukaemia Investigation Prague, Charles University, Prague, Czech Republic $u Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Rob, Lukáš $u Third Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic $u University Hospital Kralovské Vinohrady, Prague, Czech Republic
- 700 1_
- $a Vaňhara, Petr $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
- 700 1_
- $a Heneberg, Petr $u Third Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic. petr.heneberg@lf3.cuni.cz
- 773 0_
- $w MED00208612 $t Cancer & metabolism $x 2049-3002 $g Roč. 12, č. 1 (2024), s. 27
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39285269 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241008 $b ABA008
- 991 __
- $a 20241016081824 $b ABA008
- 999 __
- $a ok $b bmc $g 2196378 $s 1229760
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 12 $c 1 $d 27 $e 20240916 $i 2049-3002 $m Cancer & metabolism $n Cancer Metab $x MED00208612
- GRA __
- $a 324421 $p Univerzita Karlova v Praze
- GRA __
- $a 324421 $p Univerzita Karlova v Praze
- GRA __
- $a 324421 $p Univerzita Karlova v Praze
- GRA __
- $a NU21-03-00539 $p Agentura Pro Zdravotnický Výzkum České Republiky
- LZP __
- $a Pubmed-20241008